CB-38416
N/A
Report date: 2025/02/01 20:00:06
NME
Base Information
Drug NameCB-38416
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCentre Europeen de Bioprospective (CEB)
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesCentre Europeen de Bioprospective (CEB)
Active IndicationsN/A
Inactive Indications +[4]
Other Information
ATC CodeN/A
Related LinksN/A